Trials / Withdrawn
WithdrawnNCT02111018
Extracorporeal Therapy for the Removal of Myoglobin Using the CytoSorb in Patients With Rhabdomyolysis
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- CytoSorbents, Inc · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, randomized non-blinded, controlled study to assess the feasibility of the CytoSorb as an adjunct to the standard of care in patients with rhabdomyolysis requiring renal replacement therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CytoSorb Device | |
| PROCEDURE | CVVH |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2016-06-01
- First posted
- 2014-04-10
- Last updated
- 2023-04-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02111018. Inclusion in this directory is not an endorsement.